Skip to Content
Chest Disease ReportsChest Disease Reports
  • Case Report
  • Open Access

16 January 2025

Is the coexistence of pulmonary sarcoidosis and multiple sclerosis possible? An unusual case report

,
and
1
Director, Outpatient Clinic of Pulmonology “La Madonnina”, Reggio Calabria, Italy
2
General Medicine Unit, San Camillo Nursing Home, Messina, Italy
3
Head Nurse, Cardiology Department, Madonna della Consolazione Polyclinic, Reggio Calabria, Italy
*
Author to whom correspondence should be addressed.

Abstract

Neurosarcoidosis and Multiple Sclerosis (MS) are both inflammatory disorders of the Central Nervous System (CNS), often presenting with overlapping clinical features, making differential diagnosis challenging. Neurosarcoidosis affects approximately 5-15% of systemic sarcoidosis patients and can mimic MS due to similar CNS involvement. Differentiation is critical, as treatment strategies vary significantly. Recent studies highlight that Cerebrospinal Fluid (CSF) analysis can aid in distinguishing these conditions. Key markers include elevated CSF white cell count, CSF lactate levels, and the absence of oligoclonal bands specific to MS. Radiological differences, such as distinct Magnetic Resonance Imaging (MRI) findings, also contribute to accurate diagnosis. While neurosarcoidosis is less common than MS, it remains a crucial differential diagnosis due to its potential for severe neurological outcomes. Further research is needed to refine non-invasive diagnostic criteria, potentially reducing reliance on CNS biopsy for definitive diagnosis.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.